Next Article in Journal
Protein-Based Blood Substitutes: Recent Attempts at Controlling Pro-Oxidant Reactivity with and Beyond Hemoglobin
Next Article in Special Issue
Clinical Pharmacology of Furosemide in Neonates: A Review
Previous Article in Journal
Diamidines versus Monoamidines as Anti-Pneumocystis Agents: An in Vivo Study
Open AccessReview

Role of Diuretics and Ultrafiltration in Congestive Heart Failure

University of Colorado Division of Renal Diseases and Hypertension, 12700 East 19th Avenue, C281, Aurora, CO 80045, USA
Author to whom correspondence should be addressed.
Pharmaceuticals 2013, 6(7), 851-866;
Received: 21 March 2013 / Revised: 21 May 2013 / Accepted: 14 June 2013 / Published: 4 July 2013
(This article belongs to the Special Issue Diuretics)
Volume overload in heart failure (HF) results from neurohumoral activation causing renal sodium and water retention secondary to arterial underfilling. Volume overload not only causes signs and symptoms of congestion, but can impact myocardial remodeling and HF progression. Thus, treating congestion is a cornerstone of HF management. Loop diuretics are the most commonly used drugs in this setting. However, up to 30% of the patients with decompensated HF present with loop-diuretic resistance. A universally accepted definition of loop diuretic resistance, however, is lacking. Several approaches to treat diuretic-resistant HF are available, including addition of distal acting thiazide diuretics, natriuretic doses of mineralocorticoid receptor antagonists (MRAs), or vasoactive drugs. Slow continuous veno-venous ultrafiltration is another option. Ultrafiltration, if it is started early in the course of HF decompensation, may result in prominent decongestion and a reduction in re-hospitalization. On the other hand, ultrafiltration in HF patients with worsening renal function and volume overload after aggressive treatment with loop diuretics, failed to show benefit compared to a stepwise pharmacological approach, including diuretics and vasoactive drugs. Early detection of congested HF patients for ultrafiltration treatment might improve decongestion and reduce readmission. However, the best patient characteristics and best timing of ultrafiltration requires further evaluation in randomized controlled studies. View Full-Text
Keywords: cardiac failure; diuretic resistance; diuretic combinations; ultrafiltration cardiac failure; diuretic resistance; diuretic combinations; ultrafiltration
Show Figures

Figure 1

MDPI and ACS Style

Shchekochikhin, D.; Al Ammary, F.; Lindenfeld, J.A.; Schrier, R. Role of Diuretics and Ultrafiltration in Congestive Heart Failure. Pharmaceuticals 2013, 6, 851-866.

AMA Style

Shchekochikhin D, Al Ammary F, Lindenfeld JA, Schrier R. Role of Diuretics and Ultrafiltration in Congestive Heart Failure. Pharmaceuticals. 2013; 6(7):851-866.

Chicago/Turabian Style

Shchekochikhin, Dmitry; Al Ammary, Fawaz; Lindenfeld, Jo Ann; Schrier, Robert. 2013. "Role of Diuretics and Ultrafiltration in Congestive Heart Failure" Pharmaceuticals 6, no. 7: 851-866.

Find Other Styles

Article Access Map by Country/Region

Only visits after 24 November 2015 are recorded.
Search more from Scilit
Back to TopTop